Full Text (PDF)
Pharmer's Market — a recently launched collaboration among MIT, Harvard, and Crowdcast prediction markets (www.crowdcast.com) — is the first prediction market for pharmaceuticals. The website (https://pharmersmarket.crowdcast.com) harnesses collective intelligence to predict the likelihood of drugs succeeding through the three phases of clinical trials. This “prediction market” launches by examining six drugs that are currently in clinical trials for the treatment of breast cancer. It is designed to use the intelligence of the pharmaceutical and medical community at large to predict the success or failure of drugs progressing through the phases of testing.
In addition to helping predict the outcome of clinical trials, the Pharmer's Market will also help doctors and patients gain insights into the safety and efficacy of specific drugs at the early stages of clinical trials beyond information that is publicly available. The website is now live and inviting participation.
In vaccine development and manufacturing, GE Healthcare provides a suite of scalable solutions from cell culture through purification to analysis, which offer flexibility and economy, improve purity and secure quality.
Register to download these two NEW application notes:
Microcarriers and disposable bioreactors for MDCK and Vero cell culture
Secure cell propagation with adherent cells at reduced cost and with increased flexibility
DNA removal from influenza virus culture
HTPD and DoE for development and optimization of a chromatography step for the removal of host cell derived genomic DNA
Practical Considerations for DoE Implementation in Quality By Design
Contractor Responsibilities in Outsourced Pharmaceutical Quality Control Testing
Measuring Manufacturing Cost and Its Impact on Organizations
Single-Use Technology
Fluorescence-Activated Cell Sorting for CGMP Processing of Therapeutic Cells
The Roles of Bioactivity Assays in Lot Release and Stability Testing